Evidence map›Paper›PMID 40868332›Full record

ArticleBioengineering (Basel, Switzerland)2025

Two-Dimensional Latent Space Manifold of Brain Connectomes Across the Spectrum of Clinical Cognitive Decline.

Güneş Bayır, Demet Yüksel Dal, Emre Harı, Ulaş Ay, Hakan Gurvit, Alkan Kabakçıoğlu, Burak Acar

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Güneş BayırVAVlab, Department of Electrical & Electronics Engineering, Boğaziçi University, Istanbul 34342, Türkiye.ORCID 0000-0003-0128-4140
Demet Yüksel DalDepartment of Electrical & Electronics Engineering, Fatih Sultan Mehmet Vakıf University, Istanbul 34015, Türkiye.ORCID 0000-0002-4202-7960
Emre HarıHulusi Behçet Life Sciences Research Laboratory, Neuroimaging Unit, Istanbul University, Istanbul 34093, Türkiye.ORCID 0000-0002-8329-5507
Ulaş AyHulusi Behçet Life Sciences Research Laboratory, Neuroimaging Unit, Istanbul University, Istanbul 34093, Türkiye.ORCID 0000-0001-7896-3681
Hakan GurvitBehavioral Neurology and Movement Disorders Unit, Department of Neurology, Faculty of Medicine, Istanbul University, Istanbul 34093, Türkiye.ORCID 0000-0003-2908-8475
Alkan KabakçıoğluDepartment of Physics, Koç University, Istanbul 34450, Türkiye.ORCID 0000-0002-9831-3632
Burak AcarVAVlab, Department of Electrical & Electronics Engineering, Boğaziçi University, Istanbul 34342, Türkiye.ORCID 0000-0003-4818-9378

Funding

Boğaziçi University 16862Scientific and Technological Research Council of Turkey 114E053
6 · The paper itself

Abstract

Alzheimer's Disease and Dementia (ADD) progresses along a continuum of cognitive decline, typically from Subjective Cognitive Impairment (SCI) to Mild Cognitive Impairment (MCI) and eventually to dementia. While many studies have focused on classifying these clinical stages, fewer have examined whether brain connectomes encode this continuum in a low-dimensional, interpretable form. Motivated by the hypothesis that structural brain connectomes undergo complex yet compact changes across cognitive decline, we propose a Graph Neural Network (GNN)-based framework that embeds these connectomes into a two-dimensional manifold to capture the evolving patterns of structural connectivity associated with cognitive deterioration. Using attention-based graph aggregation and Principal Component Analysis (PCA), we find that MCI subjects consistently occupy an intermediate position between SCI and ADD, and that the observed transitions align with known clinical biomarkers of ADD pathology. This hypothesis-driven analysis is further supported by the model's robust separation performance, with ROC-AUC scores of 0.93 for ADD vs. SCI and 0.81 for ADD vs. MCI. These findings offer an interpretable and neurologically grounded representation of dementia progression, emphasizing structural connectome alterations as potential markers of cognitive decline.

Indexed as

Alzheimer’s disease dementiabrain connectomedisease progressiongraph neural networkslow-dimensional manifoldstructural connectivity

Identifiers

PMID40868332
PMCPMC12383352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.